27 related articles for article (PubMed ID: 38522075)
1. Transformation of marginal zone lymphoma into high-grade B-cell lymphoma expressing terminal deoxynucleotidyl transferase: A case report.
Fan ZM; Wu DL; Xu NW; Ye L; Yan LP; Li LJ; Zhang JY
World J Clin Cases; 2024 May; 12(15):2655-2663. PubMed ID: 38817237
[TBL] [Abstract][Full Text] [Related]
2. Inferior survival in high-grade B-cell lymphoma with
McPhail ED; Maurer MJ; Macon WR; Feldman AL; Kurtin PJ; Ketterling RP; Vaidya R; Cerhan JR; Ansell SM; Porrata LF; Nowakowski GS; Witzig TE; Habermann TM
Haematologica; 2018 Nov; 103(11):1899-1907. PubMed ID: 29903764
[TBL] [Abstract][Full Text] [Related]
3. Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
Bischin AM; Dorer R; Aboulafia DM
Clin Med Insights Blood Disord; 2017; 10():1179545X17692544. PubMed ID: 28579851
[TBL] [Abstract][Full Text] [Related]
4. Alternative genetic alterations of MYC, BCL2, and/or BCL6 in high-grade B-cell lymphoma (HGBL) and diffuse large B-cell lymphoma (DLBCL): Can we identify different prognostic subgroups?
Blomme S; De Paepe P; Devos H; Emmerechts J; Snauwaert S; Cauwelier B
Genes Chromosomes Cancer; 2024 Jan; 63(1):e23211. PubMed ID: 37897298
[TBL] [Abstract][Full Text] [Related]
5. MYC expression in concert with BCL2 and BCL6 expression predicts outcome in Chinese patients with diffuse large B-cell lymphoma, not otherwise specified.
Yan LX; Liu YH; Luo DL; Zhang F; Cheng Y; Luo XL; Xu J; Cheng J; Zhuang HG
PLoS One; 2014; 9(8):e104068. PubMed ID: 25090026
[TBL] [Abstract][Full Text] [Related]
6. Unexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci.
Adams T; Fuchs D; Shadoan PK; Johnstone L; Lau BM; McGhan L; Anwer F; Al-Kateb H
Cancer Genet; 2018 Apr; 222-223():25-31. PubMed ID: 29666005
[TBL] [Abstract][Full Text] [Related]
7. High-grade B-cell lymphoma with a quadruple-hit genetic profile including concurrent MYC, BCL2, BCL6, and CCND1 gene rearrangements.
Gagnon MF; Meyer RG; Weaver EJ; Wood AJ; Dupuy DA; Menachery SJ; Shi M; Baughn LB; Ketterling RP; Peterson JF
Lab Med; 2024 Mar; ():. PubMed ID: 38522075
[TBL] [Abstract][Full Text] [Related]
8. [Treatment strategy for high-grade B-cell lymphoma].
Maruyama D
Rinsho Ketsueki; 2018; 59(10):2109-2116. PubMed ID: 30305516
[TBL] [Abstract][Full Text] [Related]
9. Current Treatment of Burkitt Lymphoma and High-Grade B-Cell Lymphomas.
Johnson PC; Abramson JS
Oncology (Williston Park); 2022 Aug; 36(8):499-505. PubMed ID: 36001789
[TBL] [Abstract][Full Text] [Related]
10. Double-Hit Lymphoma (MYC and BCL6) with Involvement of Skull and Adnexal Lesions: A Case Report and a Review of the Literature.
Minhas H; Abdelmalek C; Khan M; O'Donnell JE; Gotlieb V; Wang JC
Am J Case Rep; 2018 Aug; 19():1035-1041. PubMed ID: 30158513
[TBL] [Abstract][Full Text] [Related]
11. [MYC-associated B-cell lymphomas: pathophysiology and treatment].
Nitta H
Rinsho Ketsueki; 2019; 60(3):155-164. PubMed ID: 31068510
[TBL] [Abstract][Full Text] [Related]
12. Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements.
Sesques P; Johnson NA
Blood; 2017 Jan; 129(3):280-288. PubMed ID: 27821509
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
